Search Results
TAILORx: Phase 3 trial validating a 21-gene expression assay in breast cancer
TAILORx: Prospective phase 3 trial validating a 21-gene expression assay in breast cancer
Assessing the Role of 21-Gene Assays in Breast Cancer
ROXANE: impact of 21-gene assay on treatment for early breast cancer
Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score TAILORx RCT
What is the TAILORX Clinical Trial?
Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)
Does 21-gene recurrence score assay testingchange decisions? Dr. Adher Alsayed ( Day 1)
Current status and future prospective of Trial Assigning IndividuaLized Options for Treatment (Rx)
Molecular Testing in Breast Cancer: Will it Become Standard Practice? - Kimberly Allison, MD
Oncotype DX Breast Recurrence Score Assay after TAILORx and RxPONDER: What’s Next?